Literature DB >> 19152799

Model for substrate interactions in C5a peptidase from Streptococcus pyogenes: A 1.9 A crystal structure of the active form of ScpA.

Todd F Kagawa1, Maurice R O'Connell, Pania Mouat, Max Paoli, Paul W O'Toole, Jakki C Cooney.   

Abstract

The crystal structure of an active form of ScpA has been solved to 1.9 A resolution. ScpA is a multidomain cell-envelope subtilase from Streptococcus pyogenes that cleaves complement component C5a. The catalytic triad of ScpA is geometrically consistent with other subtilases, clearly demonstrating that the additional activation mechanism proposed for the Streptococcus agalactiae homologue (ScpB) is not required for ScpA. The ScpA structure revealed that access to the catalytic site is restricted by variable regions in the catalytic domain (vr7, vr9, and vr11) and by the presence of the inserted protease-associated (PA) domain and the second fibronectin type III domains (Fn2). Modeling of the ScpA-C5a complex indicates that the substrate binds with carboxyl-terminal residues (65-74) extended through the active site and core residues (1-64) forming exosite-type interactions with the Fn2 domain. This is reminiscent of the two-site mechanism proposed for C5a binding to its receptor. In the nonprime region of the active site, interactions with the substrate backbone are predicted to be more similar to those observed in kexins, involving a single beta-strand in the peptidase. However, in contrast to kexins, there would be diminished emphasis on side-chain interactions, with little charged character in the S3-S1 and S6-S4 subsites occupied by the side chains of residues in vr7 and vr9. Substrate binding is anticipated to be dominated by ionic interactions in two distinct regions of ScpA. On the prime side of the active site, salt bridges are predicted between P1', P2', and P7' residues, and residues in the catalytic and PA domains. Remote to the active site, a larger number of ionic interactions between residues in the C5a core and the Fn2 domain are observed in the model. Thus, both PA and Fn2 domains are expected to play significant roles in substrate recognition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19152799     DOI: 10.1016/j.jmb.2008.12.074

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  17 in total

1.  Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of SpyCEP, a candidate antigen for a vaccine against Streptococcus pyogenes.

Authors:  Francesca Abate; Enrico Malito; Fabiana Falugi; Immaculada Margarit Y Ros; Matthew James Bottomley
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-09-28

Review 2.  Subterfuge and sabotage: evasion of host innate defenses by invasive gram-positive bacterial pathogens.

Authors:  Cheryl Y M Okumura; Victor Nizet
Journal:  Annu Rev Microbiol       Date:  2014-06-18       Impact factor: 15.500

3.  Structural basis for Ca2+-independence and activation by homodimerization of tomato subtilase 3.

Authors:  Christian Ottmann; Rolf Rose; Franziska Huttenlocher; Anna Cedzich; Patrick Hauske; Markus Kaiser; Robert Huber; Andreas Schaller
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

Review 4.  Protease-dependent mechanisms of complement evasion by bacterial pathogens.

Authors:  Michal Potempa; Jan Potempa
Journal:  Biol Chem       Date:  2012-09       Impact factor: 3.915

5.  Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics.

Authors:  Mark R Davies; Liam McIntyre; Ankur Mutreja; Jake A Lacey; John A Lees; Rebecca J Towers; Sebastián Duchêne; Pierre R Smeesters; Hannah R Frost; David J Price; Matthew T G Holden; Sophia David; Philip M Giffard; Kate A Worthing; Anna C Seale; James A Berkley; Simon R Harris; Tania Rivera-Hernandez; Olga Berking; Amanda J Cork; Rosângela S L A Torres; Trevor Lithgow; Richard A Strugnell; Rene Bergmann; Patric Nitsche-Schmitz; Gusharan S Chhatwal; Stephen D Bentley; John D Fraser; Nicole J Moreland; Jonathan R Carapetis; Andrew C Steer; Julian Parkhill; Allan Saul; Deborah A Williamson; Bart J Currie; Steven Y C Tong; Gordon Dougan; Mark J Walker
Journal:  Nat Genet       Date:  2019-05-27       Impact factor: 38.330

6.  Functional insight into the C-terminal extension of halolysin SptA from haloarchaeon Natrinema sp. J7.

Authors:  Zhisheng Xu; Xin Du; Tingting Li; Fei Gan; Bing Tang; Xiao-Feng Tang
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

7.  Characterization of a New S8 serine Protease from Marine Sedimentary Photobacterium sp. A5-7 and the Function of Its Protease-Associated Domain.

Authors:  Hui-Juan Li; Bai-Lu Tang; Xuan Shao; Bai-Xue Liu; Xiao-Yu Zheng; Xiao-Xu Han; Ping-Yi Li; Xi-Ying Zhang; Xiao-Yan Song; Xiu-Lan Chen
Journal:  Front Microbiol       Date:  2016-12-22       Impact factor: 5.640

8.  Multi-functional mechanisms of immune evasion by the streptococcal complement inhibitor C5a peptidase.

Authors:  Nicola N Lynskey; Mark Reglinski; Damien Calay; Matthew K Siggins; Justin C Mason; Marina Botto; Shiranee Sriskandan
Journal:  PLoS Pathog       Date:  2017-08-14       Impact factor: 6.823

9.  Expanding the biotechnology potential of lactobacilli through comparative genomics of 213 strains and associated genera.

Authors:  Zhihong Sun; Hugh M B Harris; Angela McCann; Chenyi Guo; Silvia Argimón; Wenyi Zhang; Xianwei Yang; Ian B Jeffery; Jakki C Cooney; Todd F Kagawa; Wenjun Liu; Yuqin Song; Elisa Salvetti; Agnieszka Wrobel; Pia Rasinkangas; Julian Parkhill; Mary C Rea; Orla O'Sullivan; Jarmo Ritari; François P Douillard; R Paul Ross; Ruifu Yang; Alexandra E Briner; Giovanna E Felis; Willem M de Vos; Rodolphe Barrangou; Todd R Klaenhammer; Page W Caufield; Yujun Cui; Heping Zhang; Paul W O'Toole
Journal:  Nat Commun       Date:  2015-09-29       Impact factor: 14.919

10.  Progress toward a group B streptococcal vaccine.

Authors:  Joon Young Song; Jae Hyang Lim; Sangyong Lim; Zhi Yong; Ho Seong Seo
Journal:  Hum Vaccin Immunother       Date:  2018-07-16       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.